Dr.
Mark S. Heywood
M.D., F.R.C.S.C.
Clinical Professor Emeritus/Emerita
Division of Gynaecologic Oncology
Biography
Teaching
Research Interests/Skills
Publications
Grants
National Cancer Institute
Efficacy of psychoeducation and Zestra for sexual dysfunction after radiation therapy
PI: Brotto LA Co: Aquino-Parsons C, Ehlen TG, Heywood MS, Lim P, Miller DM, Stuart G
Canadian Institue of Health Research
Advanced ovarian cancer and sexuality: Development of a psychoeducational intervention to reduce distress
PI: Brotto LA Co: Balneaves L, Ehlen TG, Heywood MS, Plante M, Miller DM, Hoskins P, Stuart G, Pike J
National Cancer Institute of Canada
Advanced ovarian cancer and sexuality: Development of a psychoeducational intervention to reduce distress
PI: Brotto LA Co: Balneaves L, Ehlen TG, Heywood MS, Plante M, Miller DM, Hoskins P, Stuart G, Pike J
Cancer Care Manitoba
Local pilot study of IFN-alpha and Tamoxifen in resistant ovarian cancer
PI: Lotocki RJ Co: Heywood MS
National Cancer Institute of Canada
Upfront debulking vs upfront chemotherapy for ovarian cancer
PI: Lotocki RJ Co: Heywood MS
National Cancer Institute of Canada
Cisplatin/topotecan/carbo/taxol vs taxol/carbo for advanced ovarian cancer
PI: Lotocki RJ Co: Heywood MS
Schering
Caelyx and carboplatin in relapsed ovarian cancer
PI: Lotocki RJ Co: Heywood MS
GlaxoSmithKline
Topotecan and cisplatin in relapsed squamous cervix
PI: Lotocki RJ Co: Heywood MS